Masimo CEO Joe Kiani unveiled his determination to continue the legal battle with Apple, citing that his potential success could bring better changes in Apple for the future.
Read Also: Apple Watch Back on Sale After US Ban Lifts
Masimo Spends Around $100 Million to Fight Apple
The medical device maker, Masimo, is known for pioneering a better method of measuring blood-oxygen levels. The feature is the main point of the patent infringement case as Apple allegedly copied it on their Apple Watch Series 9 and Ultra 2.
In an in-depth interview with The Wall Street Journal, the CEO confirmed that the company has spent around $100 million in pursuit of filing a case against the tech giant. Masimo initially claimed victory, resulting in the ban of Apple Watch sales.
The sales have now resumed as the company offered an appeal to make the necessary changes to avoid any legal dispute. The court is now weighing on these changes and has to put on a final decision by January 12.
Masimo Remains Firm to Fight Apple
Kiana vowed that the legal fight would continue and the settlement would be off the table unless Apple vowed to pay for his technology. In addition, the CEO also wants the tech giant to change how it interacts with smaller companies.
During the interview, Kiani revealed that some people are calling him crazy for going against Apple, a company that has unlimited resources to fight. "If I can do it, it might change Apple for the better," he emphasized.
On the other hand, Apple remained firm that the company did not steal Masimo's technology.
"We deeply respect intellectual property and innovation and do not take or use confidential information from other companies. We will continue to protect the innovations we advance on behalf of our customers against false claims," an Apple spokesperson said.
Related Article: Apple Targets Long-Term Software Fix to Avoid Patent-Infringement, Sales Ban
